Navigation Links
Dr. Donnica Moore Advocates that Women Follow a Preventive Dental Health Routine that Includes Crest Pro-Health Enamel Shield
Date:7/1/2009

-- Crest Pro-Health Enamel Shield toothpaste creates a micro-thin shield against acid attack --

CINCINNATI, July 1 /PRNewswire/ -- Leading women's health expert, Donnica L. Moore, MD, wants women to know that their dental health is important to their overall wellness. She recommends Crest and Oral-B Pro-Health products because they offer preventive solutions that can be easily integrated into a daily health regimen.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090701/NY38331 )

"Our bodies' health - particularly as we age - requires that we take precautionary measures to strengthen ourselves," explains Donnica L. Moore, MD, women's health expert and advocate, physician educator and media commentator. "This includes tooth enamel. A daily regimen of brushing and rinsing with products containing enamel-strengthening ingredients, like new Crest Pro-Health Enamel Shield, will help shield smiles against enamel loss."

Enamel loss can occur when acids from everyday food and beverages, such as fruit, yogurt, salsa, orange juice and sports drinks, attack the tooth surface. If left untreated, the result can be irreversible enamel loss, which can lead to larger issues such as cavities, sensitivity, veneers, dentures and even oral surgery.

Crest Pro-Health Enamel Shield toothpaste contains the active ingredient Stannous Fluoride, which binds to enamel to create a micro-thin shield against acid attack. It also contains finer ActivClean Crystals(TM) for a smoother brushing experience and Dual Silica Technology for gentle cleaning. All Crest Pro-Health toothpastes protect all these areas dentists check most: cavities, gingivitis, p
'/>"/>

SOURCE Crest
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Multivu Video Feed: JDRF International Chairman Mary Tyler Moore Testifies on the Need for Federal Funding for Type 1 Diabetes Research
2. Moores UCSD Cancer Center Luau and Longboard Invitational Announce Dr. David Easter to Receive the 2009 Rell Sunn Queen of Makaha Award
3. Moores UCSD Cancer Center studying novel leukemia vaccine for high-risk patients
4. Novel Lung Cancer Vaccine Trial Launched at Moores UCSD Cancer Center
5. China Sky One Medical, Inc. Engages Moore Stephens as New Independent Auditor
6. Zounds Hearing Enters Moorestown and Announces $225,000 Hearing Partnership With Twilight Wish Foundation
7. Michael Moore Defends 9/11 Rescue Workers and Criticizes Insurance Industry on California Nurses Association Press Call
8. Crystal Light and Mandy Moore Launch Unique Online Wellness Community for Women
9. The Legendary Sir Roger Moore to be Honored at The Thalians 52nd Anniversary Gala On October 21, 2007 at the Beverly Hilton Hotel to Benefit The Thalians Mental Health Center at Cedars Sinai
10. Old at Age 3: The Inspiring Life of Progeria Patient Zachary Moore
11. William Moore Appointed to IRIDEX Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 2Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 3Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Chiropractic Marketing Online Coach Launches First of a Kind Wealth Club for Chiropractors 59719 1Chiropractic Marketing Online Coach Launches First of a Kind Wealth Club for Chiropractors 59719 2Athens Consulting Volunteers Time To Habitat For Humanity 59714 1Athens Consulting Volunteers Time To Habitat For Humanity 59714 2Migraine sufferers more prone to hangover headache 59709 1Migraine sufferers more prone to hangover headache 59709 2